Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Findings add weight to WHO malaria pregnancy guidance

Findings add weight to WHO malaria pregnancy guidance

New approach could make gene therapy dramatically more effective for HIV patients

New approach could make gene therapy dramatically more effective for HIV patients

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

New progestogen-only treatment effective in stopping acute abnormal uterine bleeding

New progestogen-only treatment effective in stopping acute abnormal uterine bleeding

Medgenics closes public offering of 5,600,000 shares of common stock and warrants

Medgenics closes public offering of 5,600,000 shares of common stock and warrants

Diastolic hypotension key predictor of admission in pediatric asthma

Diastolic hypotension key predictor of admission in pediatric asthma

Selumetinib shows high response rate for patients with low-grade serous ovarian cancer

Selumetinib shows high response rate for patients with low-grade serous ovarian cancer

Northwestern Medicine expert offers tips to battle seasonal affective disorder

Northwestern Medicine expert offers tips to battle seasonal affective disorder

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

Celgene's Pomalyst receives FDA approval for treatment of multiple myeloma

Celgene receives FDA approval for POMALYST to treat multiple myeloma

Celgene receives FDA approval for POMALYST to treat multiple myeloma

Scientists create nanoscale vehicle to battle cancer without harming healthy cells

Scientists create nanoscale vehicle to battle cancer without harming healthy cells

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

Scientists identify specific cellular events that appear key to lupus

Scientists identify specific cellular events that appear key to lupus

Topline results from Gilead’s FISSION and NEUTRINO Phase 3 studies on HCV infection

Topline results from Gilead’s FISSION and NEUTRINO Phase 3 studies on HCV infection

Oral toxicity is frequent limitation of mTOR therapy

Oral toxicity is frequent limitation of mTOR therapy

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Libya becomes the first country to use Masimo Pronto-7 hemoglobin spot-check device

Libya becomes the first country to use Masimo Pronto-7 hemoglobin spot-check device

Acceleron commences ACE-536 phase 2 study in myelodysplastic syndromes

Acceleron commences ACE-536 phase 2 study in myelodysplastic syndromes

Paper says hospitals that do treat patients with anemia have better outcomes

Paper says hospitals that do treat patients with anemia have better outcomes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.